Anne-Lise Børresen-Dale

Image of Anne-Lise Børresen-Dale
Norwegian version of this page
Username
Visiting address Forskningsveien 2 A OUS Rikshospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo
Tags: Molecular biology, Life science

Publications

  • Ahearn, Thomas U.; Zhang, Haoyu; Michailidou, Kyriaki; Milne, Roger L.; Bolla, Manjeet K. & Dennis, Joe [Show all 205 contributors for this article] (2022). Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research. ISSN 1465-5411. 24(1). doi: 10.1186/s13058-021-01484-x.
  • Dorling, Leila; Carvalho, Sara; Allen, Jamie; González-Neira, Anna; Luccarini, Craig & Wahlström, Cecilia [Show all 176 contributors for this article] (2021). Breast cancer risk genes - Association analysis in more than 113,000 women. New England Journal of Medicine. ISSN 0028-4793. 384(5), p. 428–439. doi: 10.1056/NEJMoa1913948.
  • Park, Hanla A.; Neumeyer, Sonja; Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Show all 50 contributors for this article] (2021). Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer. ISSN 0007-0920. 125(8), p. 1135–1145. doi: 10.1038/s41416-021-01432-8. Full text in Research Archive
  • Johnson, Nichola; Maguire, Sarah; Morra, Anna; Kapoor, Pooja Middha; Tomczyk, Katarzyna & Kristensen, Vessela N. [Show all 50 contributors for this article] (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer. ISSN 0007-0920. 124, p. 842–854. doi: 10.1038/s41416-020-01185-w. Full text in Research Archive
  • Rye, Inga Hansine; Huse, Kanutte; Josefsson, Sarah Elisabet; Kildal, Wanja; Danielsen, Håvard Emil Greger & Schlichting, Ellen [Show all 28 contributors for this article] (2021). Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Molecular Oncology. ISSN 1574-7891. 16(1), p. 88–103. doi: 10.1002/1878-0261.13047. Full text in Research Archive
  • Morra, Anna; Escala-Garcia, Maria; Beesley, Jonathan; Keeman, Renske; Canisius, Sander & Ahearn, Thomas U. [Show all 50 contributors for this article] (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research. ISSN 1465-5411. 23:86(1), p. 1–18. doi: 10.1186/s13058-021-01450-7. Full text in Research Archive
  • Fores-Martos, Jaume; Cervera-Vidal, Raimundo; Sierra-Roca, Julia; Lozano-Asencio, Carlos; Fedele, Vita & Cornelissen, Sten [Show all 19 contributors for this article] (2021). Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3 <sup>VNTR</sup> polymorphisms and gene co-expression. NPJ breast cancer. ISSN 2374-4677. 7(1). doi: 10.1038/s41523-021-00329-2.
  • Haugen, Mads Haugland; Lingjærde, Ole Christian; Hedenfalk, Ingrid; Garred, Øystein; Borgen, Elin & Loman, Niklas [Show all 12 contributors for this article] (2021). Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers. JCO Precision Oncology (JCO PO). 5, p. 286–306. doi: 10.1200/PO.20.00086. Full text in Research Archive
  • Terkelsen, Thilde; Pernemalm, Maria; Gromov, Pavel; Børresen-Dale, Anne-Lise; Krogh, Anders & Haakensen, Vilde Drageset [Show all 9 contributors for this article] (2021). High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers. Molecular Oncology. ISSN 1574-7891. 15(2), p. 429–461. doi: 10.1002/1878-0261.12850.
  • Erdelyi, Katalin; Ditroi, Tamas; Johansson, Henrik J.; Czikora, Agnes; Balog, Noemi & Silwal-Pandit, Laxmi [Show all 19 contributors for this article] (2021). Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proceedings of the National Academy of Sciences of the United States of America. ISSN 0027-8424. 118(45). doi: 10.1073/pnas.2100050118. Full text in Research Archive
  • Aure, Miriam Ragle; Fleischer, Thomas; Bjørklund, Sunniva; Ankill, Jørgen; Castro Mondragón, Jaime Abraham & Børresen-Dale, Anne-Lise [Show all 11 contributors for this article] (2021). Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer. Genome Medicine. ISSN 1756-994X. 13:72, p. 1–21. doi: 10.1186/s13073-021-00880-4. Full text in Research Archive
  • Escala-Garcia, Maria; Abraham, Jean; Andrulis, Irene L.; Anton-Culver, Hoda; Arndt, Volker & Børresen-Dale, Anne-Lise [Show all 51 contributors for this article] (2020). A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications. ISSN 2041-1723. 11:312, p. 1–14. doi: 10.1038/s41467-019-14100-6. Full text in Research Archive
  • Liu, Jingjing; van der Smissen, Wendy J. C. Prager; Collee, Margriet J.; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Show all 82 contributors for this article] (2020). Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. ISSN 2045-2322. 10:9688(1), p. 1–14. doi: 10.1038/s41598-020-65665-y. Full text in Research Archive
  • Bailey, Matthew H.; Meyerson, William U.; Dursi, L. Jonathan; Wang, Liang-Bo; Dong, Guanlan & Aure, Miriam Ragle [Show all 51 contributors for this article] (2020). Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications. ISSN 2041-1723. 11:4748, p. 1–27. doi: 10.1038/s41467-020-18151-y. Full text in Research Archive
  • Li, Constance H.; Prokopec, Stephenie D.; Sun, Ren X.; Yousif, Fouad; Schmitz, Nathaniel & Aure, Miriam Ragle [Show all 51 contributors for this article] (2020). Sex differences in oncogenic mutational processes. Nature Communications. ISSN 2041-1723. 11:4330, p. 1–24. doi: 10.1038/s41467-020-17359-2. Full text in Research Archive
  • Kramer, Iris; Hooning, Maartje J.; Mavaddat, Nasim; Hauptmann, Michael; Keeman, Renske & Steyerberg, Ewout W. [Show all 54 contributors for this article] (2020). Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. ISSN 0002-9297. 107(5), p. 837–848. doi: 10.1016/j.ajhg.2020.09.001.
  • ICGC/TCGA Pan-Cancer Analysis, of Whole Genomes Consortium; Campbell, Peter J.; Getz, Gad; Korbel, Jan O.; Stuart, Joshua M. & Jennings, Jennifer L. [Show all 54 contributors for this article] (2020). Pan-cancer analysis of whole genomes. Nature. ISSN 0028-0836. 578(7793), p. 82–93. doi: 10.1038/s41586-020-1969-6. Full text in Research Archive
  • Pladsen, Arne Valebjørg; Nilsen, Gro; Rueda, Oscar M.; Aure, Miriam Ragle; Borgan, Ørnulf & Liestøl, Knut [Show all 18 contributors for this article] (2020). DNA copy number motifs are strong and independent predictors of survival in breast cancer. Communications Biology. ISSN 2399-3642. 3. doi: 10.1038/s42003-020-0884-6. Full text in Research Archive
  • Gythfeldt, Hedda von der Lippe; Lien, Tonje Gulbrandsen; Tekpli, Xavier; Silwal-Pandit, Laxmi; Borgen, Elin & Garred, Øystein [Show all 15 contributors for this article] (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer. International Journal of Cancer. ISSN 0020-7136. 147(9), p. 2515–2525. doi: 10.1002/ijc.33108. Full text in Research Archive
  • Ree, Anne Hansen; Nygaard, Vigdis; Pedersen, Kjetil Boye; Heinrich, Daniel; Dueland, Svein & Bergheim, Inger Riise [Show all 25 contributors for this article] (2020). Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer?the MetAction study. Acta Oncologica. ISSN 0284-186X. p. 1–10. doi: 10.1080/0284186X.2020.1742377. Full text in Research Archive
  • Mukhopadhyay, Utpal K; Oturkar, Chetan C; Adams, Christina; Wickramasekera, Nadi; Bansal, Sanjay & Medisetty, Rajesh [Show all 19 contributors for this article] (2019). TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer. Journal of the National Cancer Institute. ISSN 0027-8874. 111(11), p. 1202–1215. doi: 10.1093/jnci/djz051.
  • Nygård, Ståle; Lingjærde, Ole Christian; Caldas, Carlos; Hovig, Eivind; Børresen-Dale, Anne-Lise & Helland, Åslaug [Show all 7 contributors for this article] (2019). PathTracer: High-sensitivity detection of differential pathway activity in tumours. Scientific Reports. ISSN 2045-2322. 9:16332, p. 1–8. doi: 10.1038/s41598-019-52529-3. Full text in Research Archive
  • Lindholm, Evita Maria; Aure, Miriam Ragle; Haugen, Mads Haugland; Sahlberg, Kristine Kleivi; Kristensen, Vessela N. & Nebdal, Daniel J.H. [Show all 9 contributors for this article] (2019). miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology. ISSN 1574-7891. 13(10), p. 2278–2296. doi: 10.1002/1878-0261.12561. Full text in Research Archive
  • Escala-Garcia, Maria; Guo, Qi; Dörk, Thilo; Canisius, Sander; Keeman, Renske & Dennis, Joe [Show all 236 contributors for this article] (2019). Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer. ISSN 0007-0920. 120(6), p. 647–657. doi: 10.1038/s41416-019-0393-x. Full text in Research Archive
  • Lai, Xiaoran; Geier, Oliver; Fleischer, Thomas; Garred, Øystein; Borgen, Elin & Funke, Simon Wolfgang [Show all 14 contributors for this article] (2019). Towards personalized computer simulation of breast cancer treatment: a multi-scale pharmacokinetic and pharmacodynamic model informed by multi-type patient data. Cancer Research. ISSN 0008-5472. 79(16), p. 4293–4304. doi: 10.1158/0008-5472.CAN-18-1804. Full text in Research Archive
  • Johansson, Henrik J.; Socciarelli, Fabio; Vacanti, Nathaniel M.; Haugen, Mads Haugland; Zhu, Yafeng & Siavelis, Ioannis [Show all 36 contributors for this article] (2019). Breast cancer quantitative proteome and proteogenomic landscape. Nature Communications. ISSN 2041-1723. 10:1600, p. 1–14. doi: 10.1038/s41467-019-09018-y. Full text in Research Archive
  • Brinkman, Arie B.; Nik-Zainal, Serena; Simmer, Femke; Rodríguez-González, F. Germán; Smid, Marcel & Alexandrov, Ludmil B. [Show all 29 contributors for this article] (2019). Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation. Nature Communications. ISSN 2041-1723. 10. doi: 10.1038/s41467-019-09828-0. Full text in Research Archive
  • Lindholm, Evita Maria; Leivonen, Suvi-Katri; Due, Eldri Undlien; Nebdal, Daniel J.H.; Git, Anna & Caldas, Carlos [Show all 8 contributors for this article] (2019). miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth. MicroRNA. ISSN 2211-5366. 8(2), p. 155–165. doi: 10.2174/2211536608666181206124922.
  • Ree, Anne Hansen; Nygaard, Vigdis; Russnes, Hege Elisabeth Giercksky; Heinrich, Daniel; Nygaard, Vegard & Johansen, Christin [Show all 13 contributors for this article] (2019). Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain. Cancer immunology research. ISSN 2326-6066. 7(5), p. 701–706. doi: 10.1158/2326-6066.CIR-18-0777. Full text in Research Archive
  • Smid, Marcel; Wilting, Saskia M.; Uhr, Katharina; Rodríguez-González, F. Germán; de Weerd, Vanja & Prager-Van der Smissen, Wendy J.C. [Show all 41 contributors for this article] (2019). The circular RNome of primary breast cancer. Genome Research. ISSN 1088-9051. 29(3), p. 356–366. doi: 10.1101/gr.238121.118. Full text in Research Archive
  • Mavaddat, Nasim; Michailidou, Kyriaki; Dennis, Joe; Lush, Michael; Fachal, Laura & Lee, Andrew [Show all 56 contributors for this article] (2018). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. ISSN 0002-9297. 104(1), p. 21–34. doi: 10.1016/j.ajhg.2018.11.002.
  • Terkelsen, Thilde; Haakensen, Vilde Drageset; Saldova, Radka; Gromov, Pavel; Hansen, Merete Kjær & Stockmann, Henning [Show all 12 contributors for this article] (2018). N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome. Molecular Oncology. ISSN 1574-7891. 12(6), p. 972–990. doi: 10.1002/1878-0261.12312.
  • Møller, Elen Kristine; Nord, Silje; Wedge, David C; Lingjærde, Ole Christian; Silwal-Pandit, Laxmi & Gythfeldt, Hedda [Show all 19 contributors for this article] (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine. ISSN 1756-994X. 10:92. doi: 10.1186/s13073-018-0601-y. Full text in Research Archive
  • Jabeen, Shakila; Espinoza, Jaime; Torland, Lilly Anne; Zucknick, Manuela; Kumar, Surendra & Haakensen, Vilde Drageset [Show all 15 contributors for this article] (2018). Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics. Oncoimmunology. ISSN 2162-4011. :e1537691. doi: 10.1080/2162402X.2018.1537691. Full text in Research Archive
  • Rye, Inga Hansine; Trinh, Anne; Sætersdal, Anna Barbro; Nebdal, Daniel J.H.; Lingjærde, Ole Christian & Almendro, Vanessa [Show all 11 contributors for this article] (2018). Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors. Molecular Oncology. ISSN 1574-7891. p. 1–18. doi: 10.1002/1878-0261.12375. Full text in Research Archive
  • Jabeen, Shakila; Zucknick, Manuela; Nome, Marianne Eikhom; dannenfelser, ruth; Fleischer, Thomas & Kumar, Surendra [Show all 15 contributors for this article] (2018). Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab. Oncoimmunology. ISSN 2162-4011. 7(11), p. e1457598-1–e1457598-15. doi: 10.1080/2162402X.2018.1457598.
  • Prasmickaite, Lina; Tenstad, Ellen; Pettersen, Solveig; Jabeen, Shakila; Egeland, Eivind Valen & Nord, Silje [Show all 12 contributors for this article] (2018). Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4. Molecular Oncology. ISSN 1574-7891. 12(9), p. 1540–1558. doi: 10.1002/1878-0261.12319. Full text in Research Archive
  • Alves, Cleidson P.; Dey-Guha, Ipsita; Kabraji, Sheheryar; Yeh, Albert C; Talele, Nilesh P & Solé, Xavier [Show all 14 contributors for this article] (2018). AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth. Molecular Cancer Therapeutics. ISSN 1535-7163. 17(1), p. 254–263. doi: 10.1158/1535-7163.MCT-16-0868.
  • Milne, Roger L; Kuchenbaecker, Karoline B; Michailidou, Kyriaki; Beesley, Jonathan; Kar, Siddhartha & Lindström, Sara [Show all 20 contributors for this article] (2017). Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. ISSN 1061-4036. 49(12), p. 1767–1778. doi: 10.1038/ng.3785.
  • Michailidou, Kyriaki; Lindström, Sara; Dennis, Joe; Beesley, Jonathan; Hui, Shirley & Kar, Siddhartha [Show all 359 contributors for this article] (2017). Association analysis identifies 65 new breast cancer risk loci. Nature. ISSN 0028-0836. 551(7678), p. 92–94. doi: 10.1038/nature24284.
  • Fleischer, Thomas; Tekpli, Xavier; Mathelier, Anthony; Wang, Shixiong; Nebdal, Daniel J.H. & Dhakal, Hari Prasad [Show all 16 contributors for this article] (2017). DNA methylation at enhancers identifies distinct breast cancer lineages. Nature Communications. ISSN 2041-1723. 8(1379). doi: 10.1038/s41467-017-00510-x. Full text in Research Archive
  • Saldova, Radka; Haakensen, Vilde Drageset; Rødland, Einar Andreas; Walsh, Ian; Stöckmann, Henning & Engebråten, Olav [Show all 7 contributors for this article] (2017). Serum N-glycome alterations in breast cancer during multimodal treatment and follow-up. Molecular Oncology. ISSN 1574-7891. 11(10), p. 1361–1379. doi: 10.1002/1878-0261.12105.
  • Davies, Helen; Morganella, Sandro; Purdie, Colin A.; Jang, Se Jin; Borgen, Elin & Russnes, Hege Elisabeth Giercksky [Show all 16 contributors for this article] (2017). Whole-genome sequencing reveals breast cancers with mismatch repair deficiency. Cancer Research. ISSN 0008-5472. 77(18), p. 4755–4762. doi: 10.1158/0008-5472.CAN-17-1083.
  • Dumeaux, Vanessa; Fjukstad, Bjørn; Fjøsne, Hans Erikssønn; Frantzen, Jan Ole; Holmen, Marit Muri & Rodegerdts, Enno [Show all 11 contributors for this article] (2017). Interactions between the tumor and the blood systemic response of breast cancer patients. PLoS Computational Biology. ISSN 1553-734X. 13(9:e1005680), p. 1–27. doi: 10.1371/journal.pcbi.1005680.
  • Østrup, Olga; Dagenborg, Vegar Johansen; Rødland, Einar Andreas; Skarpeteig, Veronica ; Silwal-Pandit, Laxmi & Grzyb, Krzysztof [Show all 13 contributors for this article] (2017). Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases. OncoTarget. ISSN 1949-2553. 8(44), p. 76290–76304. doi: 10.18632/oncotarget.19350. Full text in Research Archive
  • Cheng, Jiqiu; Demeulemeester, Jonas; Wedge, David C.; Vollan, Hans Kristian Moen; Pitt, Jason & Russnes, Hege Elisabeth Giercksky [Show all 18 contributors for this article] (2017). Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. Nature Communications. ISSN 2041-1723. 8:1221, p. 1–14. doi: 10.1038/s41467-017-01355-0. Full text in Research Archive
  • Glodzik, Dominik; Morganella, Sandro; Davies, Helen; Simpson, Peter T.; Li, Yilong & Zou, Xueqing [Show all 30 contributors for this article] (2017). A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers. Nature Genetics. ISSN 1061-4036. 49(3), p. 341–348. doi: 10.1038/ng.3771.
  • Shimelis, Hermela; Mesman, Romy L.S.; Von Nicolai, Catharina; Ehlen, Asa; Guidugli, Lucia & Martin, Charlotte [Show all 133 contributors for this article] (2017). BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Research. ISSN 0008-5472. 77(11), p. 2789–2799. doi: 10.1158/0008-5472.CAN-16-2568.
  • Silwal-Pandit, Laxmi; Langerød, Anita & Børresen-Dale, Anne-Lise (2017). TP53 mutations in breast and ovarian cancer. Cold Spring Harbor Perspectives in Medicine. ISSN 2157-1422. 7(1). doi: 10.1101/cshperspect.a026252.
  • Davies, Helen; Glodzik, Dominik; Morganella, Sandro; Yates, Lucy R.; Staaf, Johan & Zou, Xueqing [Show all 33 contributors for this article] (2017). HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nature Medicine. ISSN 1078-8956. 23(4), p. 517–525. doi: 10.1038/nm.4292.
  • Bjørklund, Sunniva Maria Stordal; Panda, Anshuman; Kumar, Surendra; Seiler, Michael; Robinson, Doug & Gheeya, Jinesh [Show all 15 contributors for this article] (2017). Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Scientific Reports. ISSN 2045-2322. 7(1). doi: 10.1038/s41598-017-05537-0. Full text in Research Archive
  • dannenfelser, ruth; Nome, Marianne Eikhom; Tahiri, Andliena; Ursini-Siegel, Josie; Vollan, Hans Kristian Moen & Haakensen, Vilde Drageset [Show all 12 contributors for this article] (2017). Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity. OncoTarget. ISSN 1949-2553. 8(34), p. 57121–57133. doi: 10.18632/oncotarget.19078. Full text in Research Archive
  • Quigley, David; Tahiri, Andliena; Luders, Torben; Riis, Margit; Balmain, Allan & Børresen-Dale, Anne-Lise [Show all 8 contributors for this article] (2017). Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue. Oncoimmunology. ISSN 2162-4011. 6(11). doi: 10.1080/2162402X.2017.1356142. Full text in Research Archive
  • Muranen, Taru A.; Greco, Dario; Blomqvist, Carl; Aittomäki, Kristiina; Khan, Sofia & Hogervorst, Frans [Show all 74 contributors for this article] (2017). Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genetics in Medicine. ISSN 1098-3600. 19(5), p. 599–603. doi: 10.1038/gim.2016.147.
  • Ju, Young Seok; Martincorena, Inigo; Gerstung, Moritz; Petljak, Mia; Alexandrov, Ludmil B. & Rahbari, Raheleh [Show all 41 contributors for this article] (2017). Somatic mutations reveal asymmetric cellular dynamics in the early human embryo. Nature. ISSN 0028-0836. 543(7647), p. 714–718. doi: 10.1038/nature21703. Full text in Research Archive
  • Samuel, Nardin; Id Said, Badr; Guha, Tanya; Novokmet, Ana; Li, Weili & Silwal-Pandit, Laxmi [Show all 10 contributors for this article] (2017). Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk. Human Mutation. ISSN 1059-7794. 38(3), p. 265–268. doi: 10.1002/humu.23154.
  • Russnes, Hege Elisabeth Giercksky; Lingjærde, Ole Christian; Børresen-Dale, Anne-Lise & Caldas, Carlos (2017). Breast cancer molecular stratification– from intrinsic subtypes to integrative clusters. American Journal of Pathology. ISSN 0002-9440. doi: 10.1016/j.ajpath.2017.04.022.
  • Silwal-Pandit, Laxmi; Nord, Silje; Gythfeldt, Hedda; Møller, Elen Kristine; Fleischer, Thomas & Rødland, Einar Andreas [Show all 25 contributors for this article] (2017). The longitudinal transcriptional response to neoadjuvant chemotherapy with and without bevacizumab in breast cancer. Clinical Cancer Research. ISSN 1078-0432. 23(16), p. 4662–4670. doi: 10.1158/1078-0432.CCR-17-0160. Full text in Research Archive
  • Ree, Anne Hansen; Russnes, Hege Elisabeth Giercksky; Heinrich, Daniel; Dueland, Svein; Pedersen, Kjetil Boye & Nygaard, Vigdis [Show all 33 contributors for this article] (2017). Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate. ESMO Open. ISSN 2059-7029. 2(2), p. 1–10. doi: 10.1136/esmoopen-2017-000158. Full text in Research Archive
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Engel, Jasper & Silwal-Pandit, Laxmi [Show all 14 contributors for this article] (2017). Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy. Metabolomics. ISSN 1573-3882. 13:37, p. 1–14. doi: 10.1007/s11306-017-1168-0. Full text in Research Archive
  • Aure, Miriam Ragle; Vitelli, Valeria; Jernström, Sandra Johanna; Kumar, Surendra; Krohn, Marit & Due, Eldri Undlien [Show all 34 contributors for this article] (2017). Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Research. ISSN 1465-5411. 19. doi: 10.1186/s13058-017-0812-y. Full text in Research Archive
  • Halvorsen, Ann Rita; Helland, Åslaug; Gromov, Pavel; Wielenga, Vera Timmermans; Talman, Maj-Lis Møller & Brünner, Nils [Show all 10 contributors for this article] (2016). Profiling of microRNAs in tumor interstitial fluid of breasttumors – a novel resource to identify biomarkers forprognostic classification and detection of cancer. Molecular Oncology. ISSN 1574-7891. 11, p. 220–234. doi: 10.1002/1878-0261.12025. Full text in Research Archive
  • Jaime A, Espinoza; Jabeen, Shakila; Batra, Richa; Papaleo, Elena; Haakensen, Vilde Drageset & Wielenga, Vera Timmermans [Show all 13 contributors for this article] (2016). Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology. ISSN 2162-4011. 5(12). doi: 10.1080/2162402X.2016.1248015.
  • Demeulemeester, Jonas; Kumar, Parveen; Møller, Elen Kristine; Nord, Silje; Wedge, David C. & Peterson, April [Show all 20 contributors for this article] (2016). Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Genome Biology. ISSN 1465-6906. 17(1). doi: 10.1186/s13059-016-1109-7.
  • Hamdi, Yosr; Soucy, Penny; Adoue, Veronique; Michailidou, Kyriaki; Canisius, Sander & Lemacon, Audrey [Show all 94 contributors for this article] (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. OncoTarget. ISSN 1949-2553. 7(49), p. 80140–80163. doi: 10.18632/oncotarget.12818.
  • Pelttari, Liisa M.; Khan, Sofia; Vuorela, Mikko; Kiiski, Johanna I.; Vilske, Sara & Nevanlinna, Viivi [Show all 98 contributors for this article] (2016). RAD51B in familial breast cancer. PLOS ONE. ISSN 1932-6203. 11(5). doi: 10.1371/journal.pone.0153788.
  • Fleischer, Thomas; Klajic, Jovana; Aure, Miriam Ragle; Louhimo, Riku; Pladsen, Arne Valebjørg & Ottestad, Lars [Show all 18 contributors for this article] (2016). DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. OncoTarget. ISSN 1949-2553. 8(1), p. 1074–1082. doi: 10.18632/oncotarget.13718.
  • Shlien, Adam; Raine, Keiran; Fuligni, Fabio; Arnold, Roland; Nik-Zainal, Serena & Dronov, Serge [Show all 38 contributors for this article] (2016). Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer. Cell reports. ISSN 2211-1247. 16(7), p. 2032–2046. doi: 10.1016/j.celrep.2016.07.028.
  • Kaveh, Fatemeh; Baumbusch, Lars Oliver; Nebdal, Daniel J.H.; Børresen-Dale, Anne-Lise; Lingjærde, Ole Christian & Edvardsen, Hege [Show all 8 contributors for this article] (2016). A systematic comparison of copy number alterations in four types of female cancer. BMC Cancer. ISSN 1471-2407. 16(913). doi: 10.1186/s12885-016-2899-4.
  • Horne, Hisani N.; Chung, Charles C.; Zhang, Han; Yu, Kai; Prokunina-Olsson, Ludmila & Michailidou, Kyriaki [Show all 114 contributors for this article] (2016). Fine-mapping of the 1p11.2 breast cancer susceptibility locus. PLOS ONE. ISSN 1932-6203. 11:e0160316(8). doi: 10.1371/journal.pone.0160316.
  • Ghoussaini, Maya; French, Juliet D.; Michailidou, Kyriaki; Nord, Silje; Beesley, Jonathan & Canisus, Sander [Show all 123 contributors for this article] (2016). Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen-receptor-positive breast cancer through FGF10 and MRPS30 regulation. American Journal of Human Genetics. ISSN 0002-9297. 99(4), p. 903–911. doi: 10.1016/j.ajhg.2016.07.017.
  • Smid, Marcel; Rodríguez-González, F. Germán; Sieuwerts, Anieta M.; Salgado, Roberto; Prager-Van Der Smissen, Wendy J.C. & Vlugt-Daane, Michelle Van Der [Show all 47 contributors for this article] (2016). Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. Nature Communications. ISSN 2041-1723. 7. doi: 10.1038/ncomms12910.
  • Robles, Ana I.; Olsen, Karina Standahl; Tsui, Dana W.T.; Georgoulias, Vassilis; Creaney, Jenette & Dobra, Katalin [Show all 18 contributors for this article] (2016). Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway. Journal of Translational Medicine. ISSN 1479-5876. 14:295. doi: 10.1186/s12967-016-1059-6. Full text in Research Archive
  • Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua & Körner, Cindy [Show all 38 contributors for this article] (2016). LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Molecular Medicine. ISSN 1757-4676. 8(9), p. 1052–1064. doi: 10.15252/emmm.201606198. Full text in Research Archive
  • Guo, Yan; Warren Andersen, Shaneda; Shu, Xiao-Ou; Michailidou, Kyriaki; Bolla, Manjeet K. & Wang, Qin [Show all 110 contributors for this article] (2016). Genetically predicted body mass index and breast cancer risk: mendelian randomization analyses of data from 145,000 women of European descent. Nature Methods. ISSN 1548-7091. 13:e1002105(8). doi: 10.1371/journal.pmed.1002105.
  • Lawrenson, Kate; Kar, Siddhartha; McCue, Karen; Kuchenbaeker, Karoline; Michailidou, Kyriaki & Tyrer, Jonathan [Show all 281 contributors for this article] (2016). Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. ISSN 2041-1723. 7:12675. doi: 10.1038/ncomms12675.
  • Zeng, Chenjie; Guo, Xingyi; Long, Jirong; Kuchenbaecker, Karoline B.; Droit, Arnaud & Michailidou, Kyriaki [Show all 237 contributors for this article] (2016). Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Research. ISSN 1465-5411. 18:64. doi: 10.1186/s13058-016-0718-0.
  • Tinholt, Mari; Sandset, Per Morten; Mowinckel, Marie-Christine; Garred, Øystein; Sahlberg, Kristine Kleivi & Kristensen, Vessela N. [Show all 10 contributors for this article] (2016). Determinants of acquired activated protein C resistance and D-dimer in breast cancer. Thrombosis Research. ISSN 0049-3848. 145, p. 78–83. doi: 10.1016/j.thromres.2016.08.003.
  • Shi, Jiajun; Zhang, Yanfeng; Zheng, Wei; Michailidou, Kyriaki; Ghoussaini, Maya & Bolla, Manjeet K. [Show all 128 contributors for this article] (2016). Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer. ISSN 0020-7136. 139(6), p. 1303–1317. doi: 10.1002/ijc.30150.
  • Lesurf, Robert; Aure, Miriam Ragle; Mørk, Hanne Håberg; Vitelli, Valeria; Lundgren, Steinar & Børresen-Dale, Anne-Lise [Show all 10 contributors for this article] (2016). Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer. Cell reports. ISSN 2211-1247. 16(4), p. 1166–1179. doi: 10.1016/j.celrep.2016.06.051. Full text in Research Archive
  • Morganella, Sandro; Alexandrov, Ludmil B.; Glodzik, Dominik; Zou, Xueqing; Davies, Helen & Staaf, Johan [Show all 33 contributors for this article] (2016). The topography of mutational processes in breast cancer genomes. Nature Communications. ISSN 2041-1723. 7:11383. doi: 10.1038/ncomms11383.
  • Petridis, Christos; Brook, Mark N.; Shah, Vandna; Kohut, Kelly; Gorman, Patricia & Caneppele, Michele [Show all 95 contributors for this article] (2016). Genetic predisposition to ductal carcinoma in situ of the breast. Breast Cancer Research. ISSN 1465-5411. 18:22. doi: 10.1186/s13058-016-0675-7.
  • Dunning, Alison M.; Michailidou, Kyriaki; Kuchenbaecker, Karoline B.; Thompson, Deborah; French, Juliet D. & Beesley, Jonathan [Show all 248 contributors for this article] (2016). Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics. ISSN 1061-4036. 48(4), p. 374–386. doi: 10.1038/ng.3521.
  • Zhao, Zhiguo; Wen, Wanqing; Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin & Zhang, Ben [Show all 118 contributors for this article] (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes and Control. ISSN 0957-5243. 27(5), p. 679–693. doi: 10.1007/s10552-016-0741-6.
  • Haakensen, Vilde Drageset; Nygaard, Vegard; Greger, Liliana; Aure, Miriam Ragle; Fromm, Bastian & Bukholm, Ida Rashida Khan [Show all 15 contributors for this article] (2016). Subtype-specific micro-RNA expression signatures in breast cancer progression. International Journal of Cancer. ISSN 0020-7136. 139(5), p. 1117–1128. doi: 10.1002/ijc.30142.
  • Pereira, B.; Chin, Suet-Feung; Rueda, Oscar M.; Vollan, Hans Kristian Moen; Provenzano, Elena & Bardwell, Helen A. [Show all 34 contributors for this article] (2016). The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nature Communications. ISSN 2041-1723. 7. doi: 10.1038/ncomms11479.
  • Haukaas, Tonje Husby; Euceda, Leslie R.; Giskeødegård, Guro F.; Lamichhane, Santosh; Krohn, Marit & Jernström, Sandra Johanna [Show all 15 contributors for this article] (2016). Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer & Metabolism. ISSN 2049-3002. 4. doi: 10.1186/s40170-016-0152-x. Full text in Research Archive
  • Sandhu, Vandana; Wedge, David C.; Lothe, Inger Marie Bowitz; Labori, Knut Jørgen; Dentro, Stefan C. & Buanes, Trond [Show all 16 contributors for this article] (2016). The genomic landscape of pancreatic and periampullary adenocarcinoma. Cancer Research. ISSN 0008-5472. 76(17), p. 5092–5102. doi: 10.1158/0008-5472.CAN-16-0658.
  • Nik-Zainal, Serena; Davies, Helen; Staaf, Johan; Ramakrishna, Manasa; Glodzik, Dominik & Zou, Xueqing [Show all 88 contributors for this article] (2016). Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. ISSN 0028-0836. 534(7605), p. 47–54. doi: 10.1038/nature17676.
  • Halvorsen, Ann Rita; Silwal-Pandit, Laxmi; Meza, Leonardo Zepeda; Vodak, Daniel; Vu, Phuong Ngoc Thi & Sagerup, Camilla Maria Troøien [Show all 11 contributors for this article] (2016). TP53 mutation spectrum in smokers and never smoking lung cancer patients. Frontiers in Genetics. ISSN 1664-8021. 7(MAY). doi: 10.3389/fgene.2016.00085.
  • Haakensen, Vilde Drageset; Steinfeld, Israel; Saldova, Radka; Shehni, Akram Asadi; Kifer, Ilona & Naume, Bjørn [Show all 9 contributors for this article] (2016). Serum N-glycan analysis in breast cancer patients - Relation to tumour biology and clinical outcome. Molecular Oncology. ISSN 1574-7891. 10(1), p. 59–72. doi: 10.1016/j.molonc.2015.08.002.

View all works in Cristin

  • Bailey, Matthew H.; Meyerson, William U.; Dursi, Lewis Jonathan; Wang, Liang-Bo; Dong, Guanlan & Liang, Wen-Wei [Show all 1,451 contributors for this article] (2020). Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y). Nature Communications. ISSN 2041-1723. 11(1). doi: 10.1038/s41467-020-20128-w.
  • Nik-Zainal, Serena; Davies, Helen; Staaf, Johan; Ramakrishna, Manasa; Glodzik, Dominik & Zou, Xueqing [Show all 88 contributors for this article] (2019). Correction to: Landscape of somatic mutations in 560 breast cancer whole-genome sequences (Nature, (2016), 534, 7605, (47-54), 10.1038/nature17676). Nature. ISSN 0028-0836. 566(7742). doi: 10.1038/s41586-019-0883-2.
  • Cheng, Jiqiu; Demeulemeester, Jonas; Wedge, David C.; Vollan, Hans Kristian Moen; Pitt, Jason J. & Russnes, Hege Elisabeth Giercksky [Show all 18 contributors for this article] (2019). Correction to: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors (Nature Communications, (2017), 8, 1, (1221), 10.1038/s41467-017-01355-0). Nature Communications. ISSN 2041-1723. 10(1). doi: 10.1038/s41467-019-08512-7.
  • Cheng, Jiqiu; Demeulemeester, Jonas; Wedge, David C.; Vollan, Hans Kristian Moen; Pitt, Jason J. & Russnes, Hege Elisabeth Giercksky [Show all 18 contributors for this article] (2018). Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. Nature Communications. ISSN 2041-1723. 9(1). doi: 10.1038/s41467-018-07842-2.
  • Kaveh, Fatemeh; Baumbusch, Lars Oliver; Nebdal, Daniel J.H.; Børresen-Dale, Anne-Lise; Lingjærde, Ole Christian & Edvardsen, Hege [Show all 8 contributors for this article] (2018). Correction: A systematic comparison of copy number alterations in four types of female cancer. BMC Cancer. ISSN 1471-2407. 18(80). doi: 10.1186/s12885-017-3766-7.
  • Haukaas, Tonje Husby; Euceda, Leslie R.; Giskeødegård, Guro F.; Schlichting, Ellen; Kåresen, Rolf & Sauer, Torill [Show all 9 contributors for this article] (2016). Prediction of clinical prognostic markers in breast cancer using MR-based metabolic profiles.
  • Haukaas, Tonje Husby; Euceda, Leslie R.; Giskeødegård, Guro F.; Lamichhane, Santosh; Krohn, Marit & Jernström, Sandra [Show all 15 contributors for this article] (2016). Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes.
  • Haukaas, Tonje Husby; Euceda, Leslie R.; Giskeødegård, Guro F.; Schlichting, Ellen; Kåresen, Rolf & Sauer, Torill [Show all 9 contributors for this article] (2016). Prediction of clinical prognostic markers in breast cancer using MR-based metabolic profiles.
  • Haukaas, Tonje Husby; Euceda, Leslie R.; Giskeødegård, Guro F.; Schlichting, Ellen; Kåresen, Rolf & Sauer, Torill [Show all 9 contributors for this article] (2016). Prediction of clinical prognostic markers in breast cancer using MR-based metabolic profiles.

View all works in Cristin

Published Apr. 13, 2011 2:53 PM - Last modified June 26, 2014 5:37 PM